Deals
Warburg Pincus Reaches Deal to Buy Biotech Firm Polyplus-Transfection
- Deal could value French firm at more than $500 million
- Warburg Pincus bid would beat bids from rival buyout firms
This article is for subscribers only.
Warburg Pincus has reached a preliminary agreement to acquire French biotechnology company Polyplus-Transfection SA from investment firm ArchiMed SAS, people with knowledge of the matter said.
The deal values Polyplus at more than $500 million, said the people, who asked not to be identified because the information is private. Warburg Pincus’s bid beat out offers from competing buyout firms, the people said.